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Abstract
Pre-mRNA processing, including 5' end capping, splicing, and 3' end cleavage/polyadenylation, are
events coordinated by transcription that can influence the subsequent export and translation of
mRNAs. Coordination of RNA processing is crucial in retroviruses such as HIV-1, where inefficient
splicing and the export of intron-containing RNAs are required for expression of the full
complement of viral proteins. RNA processing can be affected by both viral and cellular proteins,
and in this study we demonstrate that a member of the hnRNP E family of proteins can modulate
HIV-1 RNA metabolism and expression. We show that hnRNP E1/E2 are able to interact with the
ESS3a element of the bipartite ESS in tat/rev exon 3 of HIV-1 and that modulation of hnRNP E1
expression alters HIV-1 structural protein synthesis. Overexpression of hnRNP E1 leads to a
reduction in Rev, achieved in part through a decrease in rev mRNA levels. However, the reduction
in Rev levels cannot fully account for the effect of hnRNP E1, suggesting that hmRNP E1 might also
act to suppress viral RNA translation. Deletion mutagenesis determined that the C-terminal end
of hnRNP E1 was required for the reduction in Rev expression and that replacing this portion of
hnRNP E1 with that of hnRNP E2, despite the high degree of conservation, could not rescue the
loss of function.
Introduction
Prior to their export to the cytoplasm, eukaryotic pre-
mRNAs undergo a number of processing events that
include capping, splicing and 3' end processing (cleavage
of the nascent transcript and polyadenylation). These
processing events occur as the transcript is being synthe-
sized, and each one is able to influence the efficiency and
specificity of the others [1-5]. RNA processing is also
required for efficient export of the mRNA to the cytoplasm
and its translation [6-10]. Retroviruses such as HIV-1
however, export unspliced and incompletely spliced viral
RNAs normally retained in the nucleus. By encoding pro-
teins from these intron containing RNAs, retroviruses
increase their coding potential [11]. Indeed, suboptimal
splicing of the primary HIV transcript generates over 30
mRNAs, many of which (e.g. Gag, Gagpol, Vpr, Vif, Vpu
and Env) contain introns. HIV is able to overcome the
requirement for complete splicing of a transcript prior to
its export to the cytoplasm by the action of the virally
encoded protein Rev. Rev functions by forming multimers
that interact directly with a cis-acting Rev response ele-
ment (RRE). This complex is exported via an interaction
with host cellular Crm1/Exportin 1 through a pathway
normally used by snRNA [12,13].
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ing and transport of HIV-1 viral RNAs, including Sam68
[14-17], hStaufen [18,19], eIF5A [20,21] and hRIP [22].
hnRNPs are another class of proteins that associate with
nascent transcripts to influence many stages of RNA
metabolism [23-25], including that of HIV-1 [26-31]. The
hnRNP E proteins (or α-complex proteins (αCPs) or
poly(C)-binding proteins (PCBPs)) were first functionally
characterized as components of a complex that stabilizes
human α-globin [32-34]. Subsequent studies demon-
strated the existence of five major isoforms, hnRNP E1 to
hnRNP E4 and hnRNP E2-KL (a splice variant of hnRNP
E2 differing from the original by a 31 amino acid deletion
in the region between KH2 and KH3), encoded by four
genetic loci [35,36]. Since their initial characterization,
hnRNP E proteins have been implicated in a wide array of
processes including mRNA stabilization, translational
enhancement and translational silencing [32-34]. Studies
have also indicated a role for the hnRNP E proteins in the
post-transcriptional regulation of a number of viruses.
Examples include the stabilization and translational
enhancement of poliovirus RNA, and translational silenc-
ing of human papillomavirus L2 mRNA [37-39].
The hnRNP E proteins belong to the triple KH domain
containing protein family that includes hnRNP K [32]. All
of the isoforms of hnRNP E contain three repeats of the
type 1, 70 amino acid KH domain, designated KH1, KH2
and KH3. Each KH domain is able to interact independ-
ently with a target RNA sequence. Therefore, these pro-
teins have the potential for complex and highly specific
RNA interactions [40]. The hnRNP E proteins are
expressed in many human tissues and have been shown to
bind poly C regions [35,41,42], although both hnRNP E1
and hnRNP E2 have been shown to interact with mRNAs
of low C content [38]. The most highly expressed and well
characterized of the hnRNP E proteins are the hnRNP E1
and E2 isoforms, which are 89% similar at the amino acid
level [40]. While multiple splice isoforms of hnRNP E2
are known to exist, hnRNP E1 is encoded by an intronless
gene believed to be the product of a retrotransposition
event of a fully processed minor isoform of hnRNP E2
[42]. It has been suggested that the conservation of
hnRNP E1 indicates it serves a non-redundant function
although, it is presently unclear what this role might be.
In this study, we began to look for endogenous trans-act-
ing factors that acted on HIV-1 ESS3. Two of the factors
identified, were hnRNP E1 and hnRNP E2 and in this
paper, we investigate the effects of overexpression and
depletion of hnRNP E1 and E2 on HIV-1 gene expression.
We demonstrate that overexpression of hnRNP E1 but not
hnRNP E2 can inhibit expression of the Rev-dependent
RNAs encoding gp120 and p24. Our data is consistent
with hnRNP E1 acting to decrease viral mRNA translation.
Depletion of either hnRNP E1 or E2 resulted in increased
production of HIV-1 structural proteins. Domain analysis
of the protein indicates that only the two carboxy-termi-
nal KH domains of hnRNP E1 are required for its inhibi-
tory effect. The differential capacity of hnRNP E1 and E2
to modulate HIV-1 RNA processing and utilization sug-
gest that, despite their high degree of similarity, these two
proteins have distinct, non-redundant roles in modulat-
ing HIV-1 gene expression.
Results
hnRNP E proteins are enriched in ESS3a containing 
columns
Previous work by this lab has shown hnRNP A1 to be one
component of a complex that modulates the activity of
the bipartite exon splicing silencer (ESS3) found in tat/rev
exon 3 [26]. However, mutagenesis studies suggest that
binding of hnRNP A1 to the ESS3 alone is not sufficient
for full activity, indicating that other factors may play a
role in mediating ESS3 activity [26]. In a continuation of
this work, we attempted to identify additional factors that
associate with ESS3. RNA affinity columns were pro-
grammed with tandem RNA affinity purification (TRAP)-
tagged RNA transcripts of ESS3a or a mutant of ESS3a,
designated ESS3a 5-2, that results in partial loss of ESS3
function without affecting hnRNP A1 binding [26]. The
TRAP tag consists of a Streptavidin binding aptamer, S1
and two MS2 coat protein binding sites (Figure 1A). HeLa
nuclear extract was passed over the columns and eluates
fractionated by SDS-PAGE, then silver stained (Figure 1B).
Proteins enriched in the wt ESS3a sample were excised
and sequenced by mass spectrometry.
One of the sequences generated by mass spectrometry
matched a region found in both hnRNP E1 and hnRNP E2
(Figure 1C). We obtained an antibody to hnRNP E2 (kind
gift from Raul Andino) and western blotting analysis con-
firmed that hnRNP E2 was selectively retained on the wt
ESS3a column (Figure 1B), at this stage we did not have an
antibody to hnRNP E1. Work by several groups has dem-
onstrated a role for members of the hnRNP E family in the
post-transcriptional regulation of a number of viruses [37-
39]. Therefore, further study of the effects of this family of
trans-acting factors on HIV expression appeared justified.
hnRNP E1 But Not hnRNP E2 overexpression suppresses 
HIV-1 gene expression
Vectors expressing myc epitope tagged forms of hnRNP E1
and hnRNP E2 (mycE1, mycE2) were generated and con-
firmed by sequencing. These were co-transfected into 293
cells alongside the replication incompetent proviral
HxBru R-/RI- construct and CMVPLAP plasmid expressing
secreted alkaline phosphatase (SEAP). 48 hrs post trans-
fection, cells were harvested and lysates analyzed by west-
ern blot. To compare the level of expression of mycE1 andPage 2 of 18
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Identification of trans-acting factors that associate with ESS3aFigure 1
Identification of trans-acting factors that associate with ESS3a. RNA affinity columns were programmed withTRAP-
tagged RNA transcripts of ESS3a or with a mutant of ESS3adesignated ESS3a 5-2. HeLa nuclear extract was passed over the 
columns and column eluates fractionated by SDS-PAGE and silver stained. ESS3a enriched bands were excised and sequenced 
by mass spectrometry. (A) Schematic representation of HIV-1 genome. Open boxes represent the open reading frames encod-
ing the indicated viral proteins, shaded boxes indicate 5' and 3' LTRs. Also shown is a schematic of the TRAP-ESS vector. The 
construct contains a Streptavidin binding aptamer, S1 and two MS2 coat protein binding sites followed by the ESS3a sequence. 
The sequence of ESS3a is shown. The altered nucleotides of the mutant designated ESS3a 5-2 are indicated above the wild-type 
sequence. (B) Silver stain of proteins eluted from Streptavidin column with indicated RNA bait. Proteins were fractionated on 
10% SDS-PAGE. The arrow indicates the excised band. Western blot against hnRNP E2; ESS or mutant thereof are as shown 
(C) Comparison of hnRNP E1 and hnRNP E2. Boxed is the sequence generated from the excised band analyzed by mass spec-
trometry.
Retrovirology 2007, 4:28 http://www.retrovirology.com/content/4/1/28mycE2, myc blots were performed. Equal loading was
confirmed by blotting for tubulin. To determine whether
any effects on virus expression were as a result of a general
inhibition of translation, expression of secreted alkaline
phosphatase (SEAP) was also measured.
As shown in Figure 2, overexpression of mycE1 results in
the inhibition of expression of the HIV-1 proteins p55,
p24 and gp160/120, while overexpression of mycE2 has
little to no effect. The peptide expressed by the control
vector (CMVmyc 3xterm) is too small for detection by
western blotting. Some of the difference in response could
be attributed to the lower expression of mycE2 relative to
myc E1. However, higher expression of mycE2 failed to
alter HIV expression (data not shown). Modulation of
HIV protein expression by mycE1 appears to be restricted,
as no significant effect on expression of co-transfected
SEAP was observed (Figure 2B). Thus, hnRNP E1 and E2
differ in their ability to inhibit HIV-1 gene expression.
hnRNP E1/E2 overexpression has limited effects on HIV-1 
RNA levels and splicing
In light of the interaction of hnRNP E1/E2 with ESS3 and
the impact of hnRNP E1 on HIV-1 protein expression, we
anticipated that the factor might function through effects
on viral RNA processing. Therefore, we examined the
effect of mycE1/E2 overexpression on virus RNA abun-
dance and processing. 293 cells were transfected with
HIV-1 provirus and mycE1, mycE2, or myc control vec-
tors, total RNA isolated and analyzed by Northern blot.
Blots were hybridized with probe corresponding to the
LTR region found in all 3 classes (2, 4 and 9 kb) of HIV-1
RNA. Equal loading was confirmed by reprobing for
GAPDH mRNA. Analysis of multiple trials revealed that
overexpression of mycE1 results in a small decrease in all
3 classes of HIV-1 RNA (Figure 3A). In contrast, overex-
pression of mycE2 had no effect on HIV-1 RNA levels. The
effect of overexpressing mycE1 on the splicing pattern of
the 2 kb and 4 kb classes of HIV-1 RNA was determined
by RT-PCR (see [43] for more information on HIV splic-
ing). Overexpression of mycE1 or mycE2 had only minor
effects on HIV-1 splice site selection (Figures 3B, C). None
of the changes in HIV-1 RNA levels observed could readily
account for the significant reduction in viral protein
expression induced by hnRNP E1 overexpression.
hnRNP E1 or E2 knockdown increase HIV-1 gene 
expression
To complement the overexpression assays, the effect of
depleting endogenous hnRNP E1/E2 by siRNA was also
assessed. As shown in Figure 4B, depletion of each protein
was achieved within 1 day of the addition of the siRNAs.
Depletion of hnRNP E1 or E2 resulted in shifts in the
expression of HIV-1 structural proteins (Fig. 4A). Deple-
tion of hnRNP E1 or E2 resulted in increased synthesis of
HIV-1 Gag (p55, p24) and Env (gp160/120). Analysis of
co-transfected SEAP (Figure 4C) revealed a modest
increase in expression upon deletion of either hnRNP E1
or hnRNP E2, suggesting that loss of either protein has a
general small, but stimulatory effect on protein synthesis
(maximum 1.4 fold). This finding could partly explain the
effect seen with HIV-1 protein expression. Subsequent
analysis by Northern blots on viral RNA abundance failed
to reveal any significant alterations on viral RNA abun-
dance that would account for the effects observed (Fig.
4D). Analysis of individual splicing events by RT-PCR also
failed to reveal any changes upon depletion of either
hnRNP E1 or E2 (data not shown).
hnRNP E1 overexpression reduces rev synthesis
The failure of myc E1/E2 overexpression and depletion of
endogenous hnRNP E1/E2 to significantly alter HIV RNA
processing consistent with modulation of ESS3 function
lead us to examine the response in greater detail. In partic-
ular, we wanted to find the basis for hnRNP E1's drastic
inhibition of viral protein synthesis. Given that both ESE3
and ES3 encode portions of Rev and Env within the HIV-
1 provirus, testing the role of these sequences in mediat-
ing the response to hnRNP E1 is problematic. To over-
come this obstacle, mycE1 and mycE2 were co-transfected
into HeLa cells along with pgTat and the Rev expressing
plasmid SVH6Rev to determine if similar results could be
obtained using this HIV reporter construct [44]. pgTat is
an env-expressing reporter that contains the first coding
exon of Rev, but lacks much of the second coding exon
(see [26] for more information). Therefore, export of the
intron containing env RNA and subsequent env expres-
sion requires trans expression of Rev. As shown in Figure
5B, co-transfection of mycE1 with pgTat and Rev resulted
in a decrease in the level of gp160/120 expression, while
co-transfection with mycE2 had little or no effect, consist-
ent with the results from provirus transfections.
Two pgTat derivatives, pgTatΔESE (lacking the ESE but
retaining the ESS) and pgTatΔESEΔESS SL1 (where the
ESE and ESS have been replaced with a sequence of simi-
lar size from the EDA exon of the human fibronectin gene;
Figure 5A) were also used to assess the potential role of
ESE and ESS3a in mediating any effects of mycE1/E2 on
HIV RNA processing [26]. In all cases, mycE1 overexpres-
sion reduced gp160/120 expression while mycE2 overex-
pression had no effect. Consistent with previous results
[45], a low level of gp160/120 expression was observed
from pgTatΔESE which was further reduced upon expres-
sion of mycE1. The results demonstrate that the inhibitory
effect of mycE1 does not require either ESE3 or the ESS3a,
as reduced gp160/120 expression was observed for all
constructs tested (Figure 5B).Page 4 of 18
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120 expression, we first looked at whether hnRNP E1 was
altering viral RNA processing, in particular preventing the
formation of unspliced/cleaved env RNA, the preferred
substrate for Rev export [17,46]. However, only a two-fold
decrease in the level of unspliced, polyadenylated env
RNA was seen upon overexpression of mycE1 (data not
shown). This observation is consistent with the reduction
in proviral RNA seen in Figure 3A, but it is unable to fully
account for the loss of viral protein expression. Alterna-
tively, mycE1 may act indirectly by affecting Rev, as export
of env RNA is dependent upon Rev. Indeed, co-expression
of mycE1 decreased the number of Rev positive cells as
assayed by immunofluorescence (data not shown). To test
this further, we transfected cells with the Rev-dependent
reporter, GagRRE, and assessed expression of both Gag (α
p24) and Rev by Western blot in the presence or absence
of the myc-tagged hnRNP E proteins. As shown in Figures
5C and 5D, cotransfection of mycE1 with the GagRRE
reporter construct reduced both p24 production and Rev
expression. In contrast, mycE2 had no effect. No signifi-
cant change in cotransfected SEAP expression was seen,
hnRNP E1 but not E2 overexpression decreases HIV-1 structural protein levelsFigure 2
hnRNP E1 but not E2 overexpression decreases HIV-1 structural protein levels. 293 cells were transfected with 
mycE1, mycE2 or the empty CMVmyc vector, alongside provirus HxBruR-/RI- andCMVPLAP. 48 hrs post transfection, cells 
were lifted in 1×PBS and a fraction (1/4) of the cells lysed in 9 M urea, 5 mM Tris pH8 and fractionated on SDS-PAGE gels. Pro-
tein was transferred to PVDF membrane and probed with antibody to p24. Blots were stripped in 62.5 mM TrisHCl pH 6.7, 
2%SDS, 100 mM β-mercaptoethanol and reprobed with antibodies to gp160/120 (α gp120), hnRNP E1 and E2, myc and tubulin 
as indicated. (A) Results of western blotting. Antibodies and transfected plasmids are as indicated. (B) Relative SEAP expression 
in transfected cells. Levels were normalized to that of the empty CMVmyc vector control. Results shown are an average of 
three experiments. Error bars represent standard deviation.Page 5 of 18
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hnRNP E1 and E2 overexpression have only limited effects on HIV-1 RNA levelsFigure 3
hnRNP E1 and E2 overexpression have only limited effects on HIV-1 RNA levels. 293 cells were transfected with 
eithermycE1 (E1), mycE2 (E2) or CMVmyc (myc) along with provirus HxBruR-/RI- and CMV PLAP. 48 hrs post transfection, 
cells were lifted in 1×PBS and total RNA isolated. Northern and RT-PCRs were performed. (A) Northern analysis of the effect 
of mycE1/E2 overexpression on levels of 2 kb, 4 kb and 9 kb classes of HIV-1 RNA. Probe derived from the HIV-1 LTR was 
used to detect all 3 classes of viral RNA; viral RNAs (9, 4, 2 kb) are indicated. Blots were stripped and reprobed for GAPDH 
RNA to confirm equal loading. At right, a summary of 3 sets of experimental results quantitated using Image Quant v5.2. Fig-
ures are normalized to GAPDH with the results for the myc control vector set at 1 for each RNA class. Error bars show 
standard deviation. An asterisk denotes 95% confidence level that the difference between the sample and the myc control is 
significant. (B) RT-PCR showing effects of mycE1 and mycE2 on the 2 kb species of HIV-1 RNA. Reporter plasmids and identity 
of amplicons are indicated. At right, a summary of 3 sets of experimental results quantitated using Image Quant v5.2. Shown is 
the percentage of each species of the total RNA for each lane. For each species of RNA the myc value was set at 1. Error bars 
show standard deviation. An asterisk denotes 95% confidencelevel that the difference between the sample and the myc control 
is significant. (C) RT-PCR showing effects of mycE1 and mycE2 on the 4 kb species of HIV-1 RNA. Reporter plasmids and iden-
tity of amplicons are indicated. At right, a summary of 3 sets of experimental results, quantitated using Image Quant v5.2 as 
described in (B).
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Depletion of hnRNP E1 and E2 alters HIV-1 gene expressionFigure 4
Depletion of hnRNP E1 and E2 alters HIV-1 gene expression. 293 cells were transfected with siRNAs to hnRNP 
E1(E1(3) or E1(16)), hnRNP E2 (E2) or a scrambled siRNA control (scr)using Oligofectamine. 24 hrs later, cells were trans-
fected withHxBruR-/RI- provirus and CMVPLAP using Fugene. 48 hrs post transfection, cells were harvested, lysates fraction-
ated on SDS-PAGE gels and analyzed by western blot. (A) Results of western blotting. Proteins examined and siRNAs used are 
as indicated. (B) Kinetics of siRNA depletion of hnRNP E1/E2. Cells were treated with control siRNA (scrambled) or directed 
to hnRNP E1 (E1(3), E1(16)), or hnRNP E2 (E2) and harvested 24 h after transfection. Cell extracts were fractionated on SDS 
PAGE gels, transferred to PVDF membrane and probed with antibody to hnRNP E1 (E1), hnRNP E2 (E2), or tubulin (tubulin). 
(C) Relative SEAP expression in transfected cells. Media was harvested 48 hrs post transfection and assayed for SEAP activity. 
Levels were normalized to that of the scrambled siRNA control. Results shown are an average of three experiments. Error 
bars represent standard deviation. (D) Northern analysis of the effect of hnRNP E1/E2 depletion on HIV RNA levels. Cells 
were treated with siRNAs as above and total RNA extracted. Following fractionation on formaldehyde agarose gels and trans-
fer to nitrocellulose membrane, blots were probed to detect viral RNAs (9, 4, and 2 kb). Blots were reprobed for GAPDH 
RNA to confirm equal loading. Quantitation of 3 experiments is shown at right. Results were normalized to GAPDH with the 
data for the scrambled siRNA sample (scr) set at 1. Error bars show standard deviation.
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hnRNP E1 but not hnRNP E2 inhibit expression of subgenomic HIV-1 expression vectorsFigure 5
hnRNP E1 but not hnRNP E2 inhibit expression of subgenomic HIV-1 expression vectors. (A) Schematic of HIV-1 
env expression vector, pgTat, including the location of the ESE and ESS. The sequences of pgTat derivatives pgTatΔESE and 
pgTatΔESEΔESS SL1 are shown. (B) HeLa cells were co-transfected with pgTat or derivatives thereof, SVH6Rev, and hnRNP E 
expressing plasmids as indicated. 48 hours post-transfection, cells were harvested in RIPA buffer, and lysates fractionated on 
SDS-PAGE gels. Following transfer to PVDF membranes, blots were probed with antibody against gp120 and tubulin. (C) Effect 
of hnRNP E proteins on Gag/RRE expression. Shown is a diagram of the Gag expression construct used. HeLa cells were trans-
fected with Gag/RRE, hnRNP E and Rev expression constructs as indicated. 48 hrs post transfection, cells were harvested, and 
lysates fractionated on SDS-PAGE gels. Blots were probed with antibody against Rev and p24, stripped then reprobed for tubu-
lin and myc to confirm equal loading and similar expression of myc-tagged constructs respectively. To quantitate changes in Rev 
protein expression, blots were scanned and analyzed in Imagequant. Summary of 5 independent determinations is shown (D). 
(E) Effect of hnRNP E proteins on SEAP expression. Media from cells transfected with a SEAP expressing plasmid was har-
vested 48 hrs post transfection and SEAP expression normalized to that seen upon cotransfection with the CMVmyc control 
vector. Results shown are an average of 3 experiments. Error bars show standard deviation. SEAP expression of the myc con-
trol vector was set to 1.
Retrovirology 2007, 4:28 http://www.retrovirology.com/content/4/1/28suggesting that the inhibition of Rev expression by mycE1
is not a generalized effect (Figure 5E). Thus, hnRNP E1
and E2 isoforms appear to differ in their ability to inhibit
HIV-1 gene expression both from the provirus and from
HIV-1 expression constructs. Also, the response to mycE1
appears to be independent of ESS3 within the HIV-1 env
reporter. However, the sequence of ESS3 is also present in
Rev, possibly explaining why hnRNP E1 regulates its
expression.
Deletion of the C terminal KH domain of hnRNP E1 
abrogates its ability to inhibit Rev expression
The marked difference in ability of mycE1 versus mycE2 to
modulate HIV-1 expression despite their high degree of
similarity (89% at the amino acid level, see Fig. 1C) led us
to map the domains involved. A series of deletion
mutants were constructed (Figure 6A). Deletion mutants
of mycE1 which lack the N-, or C-terminal KH domains
were designated mycE1ΔN and mycE1ΔC, respectively. A
domain swap mutant was also generated consisting of the
C-terminal KH domain of hnRNP E2 with the N-terminal
KH domains 1 and 2 of hnRNP E1 (mycE1N/2C). Expres-
sion of the mutants was confirmed by Western blot (see
6C, α myc). Localization of the domain mutants was
determined by immunofluorescence (Figure 6B). Full
length mycE1 is predominately localized to the nucleus
(Figure 6B), and deletion of the N-terminal KH domain
(amino acids 1–86) did not alter this localization pattern.
However, it was noted that mycE1ΔN localized to discrete
foci within the nucleus generating a speckled appearance.
In contrast, deletion of the C-terminal 148 amino acids
(mycE1ΔC) resulted in a pronounced redistribution of the
protein to the cytoplasm. Replacement of the C-terminal
domain of hnRNP E1 with that of hnRNP E2 (mycE1N/
2C) failed to restore the nuclear accumulation of the pro-
tein, the distribution being similar to that of mycE2
(localized diffusely throughout the cell (Figure 6B)).
Given the effect of the N- and C-terminal domain mutants
on hnRNP E1 subcellular distribution, we were interested
to determine if these changes in protein localization cor-
related with a change in the ability of mycE1 to suppress
viral protein expression. 293T cells were transfected with
the env expression vector (pgTat), as well as plasmids
expressing Rev and mycE1 (or domain mutants thereof)
or mycE2. As shown in Figure 6C, mycE1ΔN mutant
retains the ability to inhibit gp160/120 and Rev expres-
sion (Figure 6C). In contrast, deletion of the C-terminal
KH domain of hnRNP E1 completely abrogates the ability
of the protein to inhibit gp160/120 and Rev expression.
Interestingly, the domain swap mutant mycE1N/2C had
reduced activity relative to mycE1 indicating that the C-
terminus of hnRNP E1 performs a unique function. As
before, no effect on Rev or gp160/120 expression was
observed upon co-expression with mycE2. None of the
constructs induced any significant alteration in expression
of cotransfected secreted alkaline phosphatase (SEAP, Fig.
6D). Thus, the C-terminal KH domain of hnRNP E1 is
required both for the localization of the protein to the
nucleus and, in part, for the inhibition of viral protein
(gp160/120, Rev) expression.
Effects of hnRNP E1 and its domain mutants on HIV-1 
RNA abundance, processing and subcellular distribution
We next looked at the effect of overexpressing hnRNP E1
or its domain mutants on splicing and cleavage/polyade-
nylation in the context of the subgenomic reporters. To do
this, a probe that spans both the 3' ss and the polyadenyla-
tion signal of pgTat was used (see Fig. 7). Four protection
products are generated corresponding to: unspliced/
uncleaved (US/UC), unspliced 3' end processed RNA (US/
C), spliced/uncleaved (S/UC), and fully processed
spliced/cleaved RNA (S/C). Protections generated were of
the expected size by comparison to molecular weight
markers [17] and experiments with RNA from mock trans-
fected cells failed to generate protection products (data
not shown). Examination of env RNA in the presence of
mycE1 and mycE1ΔN revealed a slight decrease in the
level of unspliced/cleaved RNA (US/C; Figure 7A). How-
ever, the greatest effect seen was a reduction in the levels
of spliced, cleaved (S/C) in the presence of mycE1, indi-
cating that this factor acts in a manner similar to that seen
with the provirus (Figures 3A and 7B). All constructs
tested yielded some reduction in spliced/cleaved (S/C)
RNA levels, the least active being mycE2. Little change in
unspliced/uncleaved (US/UC) env RNA is apparent in the
presence of mycE1 indicating that the effect of the protein
is limited to a subset of the viral RNAs generated.
To investigate the basis for the effect of mycE1 on Rev
expression, its effect on rev RNA abundance was also
examined. Total RNA was isolated from 293T cells trans-
fected with pgTat, and plasmids expressing Rev, and
mycE1, mutants thereof, or mycE2, and RPAs performed
using a rev specific probe. Co-transfection of a VA RNA
expression vector served as an internal control. mycE1,
mycE1ΔN, and mycE1N/2C resulted in only a modest (~2
fold) decrease in the level of rev RNA (Figure 7C, D). No
significant changes in rev RNA levels were detected upon
cotransfection with mycE1ΔC, or mycE2. Reduction in
RNA levels is observed even for those constructs lacking
an intron (SV Rev), consistent with an alteration in stabil-
ity of the affected RNAs.
Given that reduction in Rev levels might be expected to
affect the cytoplasmic accumulation of the viral RNAs
encoding the structural proteins, we examined the effect
of mycE1 and mycE2 expression on the subcellular distri-
bution of pgTat RNAs. As shown in Fig. 8A, cotransfection
of pgTat with an inactive form of Rev (M10) [47] resultedPage 9 of 18
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Suppression of HIV-1 gene expression by hnRNP E1 is dependent upon the C-terminal KH domainFigu  6
Suppression of HIV-1 gene expression by hnRNP E1 is dependent upon the C-terminal KH domain. (A) Sche-
matic of hnRNP E1 and domain mutants thereof. Light grey boxes denote the KH domains. Dark shading denotes hnRNP E2 
sequence and white indicates hnRNP E1 sequence. (B) Localization of hnRNP E1 and domain mutants and hnRNP E2. HeLa 
cells were grown on coverslips and transfected with the hnRNP E expressing plasmids. 48 hrs post transfection, cells were 
washed with 1× PBS, fixed in 4% paraformaldehyde, 1× PBS and localization of transfected hnRNP E proteins (anti-myc) and 
nuclei (DAPI) determined. Magnification is 630×. Shown are representative examples of results obtained in multiple trials. (C) 
293T cells were transfected with mycE1/E2 expressing plasmids as indicated along with pgTat and SVH6Rev. 48hrs post trans-
fection, cells were harvested and lysates fractionated on SDS-PAGE gels. Following transfer to PVDF membranes, blots were 
probed with antibody to gp120, tubulin, rev or the myc tag. Cell supernatants were analyzed for levels of SEAP expression (D).
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hnRNP E1 overrexpression selectively affects spliced HIV-1 env RNA levelsFigure 7
hnRNP E1 overrexpression selectively affects spliced HIV-1 env RNA levels. (A) Shown is a diagram of the pgTat 
vector with the line below indicating the position of the probe (spanning both the 3'ss and polyadenylation sequence) used for 
RPA analysis. 293T cells were transfected with hnRNP E expressing plasmids as indicated, alongside pgTat and SVH6Rev. RNA 
was isolated 48 hours post transfection and used in RNase protection assays. Protection products were resolved on denatur-
ing PAGE gels. Analysis of 3' end processing of unspliced env RNA by RNase protection assay. Identities of the various bands 
observed are indicated; unspliced, uncleaved (US/UC); unspliced, cleaved (US/C); spliced, uncleaved(S/UC); spliced, cleaved (S/
C). (B) Graphical representation of the effect of hnRNP E proteins on the ratio of s/c to us/uc RNA. Averages of a minimum of 
three independent experiments are shown. Asterisk denotes values that were deemed significantly different from control at p 
< 0.05 (C) 293T cells were transfected with hnRNP E expressing plasmids as indicated, alongside Gag/RRE and SVH6Rev. 48 
hrs post transfection RNA was isolated and used in RNase protection assays. Analysis of rev RNA levels by RNase protection 
assay. rev RNA abundance was corrected using the cotransfected VA control (pSPVA) and normalized to the vector control 
indicated by (-). (D) Summary of the effect of N- and C-terminal KH domain mutants of hnRNP E on rev RNA levels. Averages 
of a minimum of three independent experiments are shown. Asterisk denotes values that were deemed significantly different 
from control at p < 0.05
Retrovirology 2007, 4:28 http://www.retrovirology.com/content/4/1/28in little accumulation of the US/C form of pgTat in the
cytoplasm. In contrast, co-transfection of wild type Rev
induced accumulation of US/C form of pgTat RNA in the
cytoplasm. In addition, despite the reduction in Rev
expression, co-expression of mycE1 or mycE2 failed to
prevent the transport of the viral RNA to the cytoplasm
(Fig. 8B). Therefore, sufficient levels of Rev are present in
the presence of mycE1 to export viral RNAs. However,
translation of the viral RNA in the cytoplasm must be pre-
vented to explain the marked reduction in gp160/120
expressed observed in the presence of mycE1.
Discussion
In this study, we have demonstrated that hnRNP E1 is a
trans-acting factor able to modulate HIV-1 gene expres-
sion. This fact, coupled with the identification of hnRNP
E1 in the virion particle, suggests that this factor plays an
important role in HIV-1 expression and assembly [48].
Although hnRNP E1 were initially examined due to an
interaction with ESS3 in vitro, subsequent work deter-
mined that it does not function through altering the splic-
ing of HIV-1 RNA to any significant extent (Fig. 3B, C).
Indeed, hnRNP E1 overexpression led to dramatic sup-
pression of reporter constructs (GagRRE, pgTatΔESEΔESS/
SL1) that lacked ESS3 (Fig. 5). However, since all viral
RNAs include the terminal exon containing ESS3, the
effect of hnRNP E1 can be explained by its interaction
with the mRNAs encoding the HIV-1 regulatory proteins
Tat and Rev. Although the ESS3 lacks a polycytosine tract
similar to the consensus hnRNP E1 binding site, other
studies have demonstrated binding to sequences that do
not fit the consensus [38]. In addition, recent work has
shown that hnRNP E1 can be recruited to an RNA through
protein-protein interaction (in particular via hnRNP A2)
to modulate translation of a mRNA [49]. Given the previ-
ously determined role of hnRNP A1/A2 in mediating the
activity of ESS3 [50,51], recruitment of hnRNP E1/E2 to
this sequence may be indirect. However, the loss of
hnRNP E1/E2 binding to mutants of ESS3 that retain
hnRNP A1 binding (Fig. 1) and the independence of the
response to the presence of the ESS3 suggests that hnRNP
E1 may be interacting with sequences elsewhere in the
viral RNA. Previous work on hnRNP E1 and E2 has iden-
tified roles for these factors in the translational control of
both viral and cellular mRNAs [33,37-39,52-54] as well as
in the mediation of mRNA stabilization [55-57]. These
effects are the result of either steric protection of the
mRNA 3'UTR from endonucleolytic attack [58] or protec-
tion of the poly (A) tail from degradation by interacting
with the poly(A)-binding protein (PABP; [59-61]). Little
is known as to whether the different hnRNP E proteins
have unique functions or if they show redundancy in their
actions. In this study, we establish that hnRNP E1 and
hnRNP E2 elicit different responses as only overexpres-
sion of hnRNP E1 inhibited the expression of several HIV-
1 genes. This difference was observed in the context of
both the HIV provirus and subviral expression plasmids.
The failure to detect significant alterations in cotrans-
fected SEAP expression suggests that the response to
hnRNP E1 is somewhat restricted. Consistent with the
overexpression assays, depletion of hnRNP E1 or E2 by
siRNA resulted in increased expression of HIV-1 Gag and
Env. These findings underline the differential roles of
these factors in modulating HIV-1 gene expression.
The basis for the observed effect of hnRNP E1 remains
only partially defined. Overexpression of hnRNP E1
resulted in a decrease in the levels of Rev protein. The loss
of Rev is explained in part by effects at the RNA level.
Forms of hnRNP E1 (mycE1 and mycE1ΔN) that yielded
reduced Rev protein expression elicited a 2 fold reduction
in rev RNA abundance. A similar change in rev RNA but
not protein levels was also observed upon co-expression
of mycE1N/2C. However, the fold change in rev RNA lev-
els is not consistent with the extent of reduction in Rev
protein (decreased 5 fold, Fig, 5D). Therefore, it is likely
that the loss of Rev expression is also due to reduced trans-
lation of its RNA, a phenomenon consistent with the
known role of hnRNP E1 in translational silencing of
RNAs in other systems. A similar decrease in abundance is
also seen for the spliced form (S/C) of pgTat (Fig. 7) and
proviral RNAs (Fig. 3) although, in the context of pgTat,
all constructs except hnRNP E2 reduced S/C RNA abun-
dance by ~2 fold. However, despite reduced Rev expres-
sion, viral RNAs encoding structural proteins still
accumulate in the cytoplasm (Fig. 8). Therefore, the loss
of HIV Gag and Env expression upon hnRNP E1 overex-
pression is not due to a block in export of these RNAs but
rather an inhibition of their translation.
Deletion analysis identified domains of hnRNP E1 essen-
tial for the modulation of HIV-1 expression and revealed
a correlation with the extent of nuclear accumulation of
the protein. Analysis of the subcellular localization of our
hnRNP E1 domain mutants is consistent with earlier stud-
ies [40] that identified a nuclear localization signal (NLS)
between KH2 and KH3 of hnRNP E1. Deletion of the C-
terminal 148 amino acids from hnRNP E1 (mycE1ΔC)
resulted in the redistribution of the protein from the
nucleus to the cytoplasm. Removal of the C-terminal KH
domain also resulted in loss of inhibition of HIV-1 gene
expression. However, our work failed to show localization
of full length hnRNP E1 to nuclear speckles. Swapping the
C-terminal domain (KH3) of hnRNP E1 and E2
(mycE1N/2C) only partially restored the nuclear accumu-
lation of the mutant, the distribution of the fusion protein
being comparable to that observed for mycE2. The failure
of mycE1N/2C to inhibit Rev and p24 expression suggests
that the C-terminal domains of hnRNP E1 and E2 are not
functionally interchangeable and implicate that sequencePage 12 of 18
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Effect of hnRNP E1/E2 Overexpression on the Subcellular Distribution of Viral RNAsFigure 8
Effect of hnRNP E1/E2 Overexpression on the Subcellular Distribution of Viral RNAs. 293T cells were transfected 
with control (CMVpA) or mycE1/E2 expression plasmids as indicated, alongside pgTat and either an inactive form of Rev (M10) 
(A) or wild type Rev (B). Following harvest, nuclear and cytoplasmic fractions were prepared, RNA extracted and used in 
RNase protection assays. Protection products were resolved on denaturing PAGE gels. Identities of the various bands 
observed are indicated; unspliced, uncleaved (US/UC); unspliced, cleaved (US/C); spliced, uncleaved (S/UC); spliced, cleaved (S/
C).
Retrovirology 2007, 4:28 http://www.retrovirology.com/content/4/1/28differences in this region partially account for the different
activities of these two proteins.
In summary, despite high levels of sequence identity
between the hnRNP E1 and E2 isoforms, the emerging
model is that these proteins are capable of fulfilling dis-
tinct cellular functions. These differences are reflected in
the failure of domain swaps to maintain the activity of the
proteins. The isoform specific effects for these highly sim-
ilar proteins is surprising. Work by other groups has also
suggested differential roles for hnRNP E1 and hnRNP E2.
This includes the finding that hnRNP E1 has a greater
affinity for AUF/hnRNP D than hnRNP E2 [61], as well as
differential regulation of hnRNP E1 and E2 in response to
hypoxic stressing of cortical neurons [62]. This observa-
tion supports the notion that despite a high degree of sim-
ilarity at the amino acid level, these proteins possess non-
redundant functions. To our knowledge, the present work
is among the few examples of a system that allows for
examination of the unique effects of the hnRNP E iso-
forms. Further analysis using this system may allow us to
elucidate the amino acid differences between hnRNP E1
and E2 that account for their differential effect on HIV-1
RNA metabolism and refine the mechanism by which
hnRNP E1 modulates HIV-1 expression.
Materials and methods
Expression constructs
The following plasmids have been previously described:
SVH6Rev, pgTat, pgTatΔESE, pgTatΔESEΔESS SL1, pgTat-
ΔESE S5-2, Gag RRE, pSPVA, HxBruR-/RI- [26,47]. pTRAP
plasmid was generously provided by Dr. H. Krause, Uni-
versity of Toronto. CMVmycE1 was constructed by ampli-
fying HeLa cDNA with primers hnRNP E1-F-Hind (5' CCC
AAG CTT ATG GAT GCC GGT GTG ACT GAA 3') and
hnRNPE1-R-Pst (5' AAA ACT GCA GCT AGC TGC ACC
CCA TGC CCT T 3'). The resulting amplicon was digested
with HindIII/PstI and cloned into the corresponding sites
of the CMVmyc3xterm vector (a N-terminal myc-tagged
CMV immediate early promoter, with a 3xterm cassette
and SV40 polyadenylation signal in a Bluescript (Strata-
gene) backbone). CMVmycE2 was constructed by ampli-
fying HeLa cDNA with primers hnRNPE2-F-Hind (5' CCC
AAG CTT ATG GAC ACC GGT GTG ATT GAA 3') and
hnRNPE2-R-Bam (5' CGC GGA TCC CTA GCT GCT CCC
CAT GCC ACC 3'). The resulting amplicon was HindIII/
BamHI digested and cloned into the corresponding sites
of the CMVmyc3Xterm vector. CMVmycE1ΔN was con-
structed by amplifying CMVmycE1 with primers
E1Δ1FHind (5' CCC AAG CTT ATG ACC AAC AGT ACC
GCG GCC 3') and hnRNPE1-R-Pst. Amplicons were Hin-
dIII/PstI digested and cloned into the corresponding sites
of CMVmyc3xterm. CMVmycE1ΔC was constructed by
digesting CMVmycE1 with XbaI and religating the back-
bone. CMVmycE1N/2C was constructed by ligating the
500 bp fragment generated upon XbaI digest of
CMVmycE2 with the CMVmycE1 XbaI digested backbone.
pTRAP ESS and S5-2 were constructed by PCR amplifica-
tion of pgTatΔESE and pgTatΔESE S5-2 with primers ESS-
F (5' CCC AAG CTT GGG ATC CCC GAA GAA ATA GTG
G 3') and ESS-R (5' CCG CTC GAG GCC AAG GTC TGA
AGG TCA CTC GA 3'). Amplicons were digested with Hin-
dIII and XhoI and cloned into the corresponding sites of
pTRAP. All constructs were confirmed by sequencing.
Transfections and SEAP assays
HeLa, 293 and 293T cells were maintained in Iscove's
modified Dulbecco's media (IMDM) supplemented with
10% fetal bovine serum (FBS), 50 μg/ml gentamycin sul-
fate and 2.5 μg/ml amphotericin B. For transient expres-
sion studies, vectors were introduced by calcium
phosphate transfection [63]. Transfections using HIV-1
provirus, were performed using 1:2:0.5 ratio (provirus :
CMVmyc expression construct : CMVPLAP). Transfections
using HIV-1 expression constructs were performed at
1:4:0.4 ratio (HIV-1 expression construct (pgTat and
derivatives thereof or GagRRE) : CMVmyc expression con-
struct : Rev expressing construct), depending on the exper-
iment either 0.4 μg VA or 0.5 μg CMVPLAP was also
included.
Cell lysates were prepared by harvesting cells 48 hrs post
transfection in either RIPA buffer (50 mM Tris-HCl pH
7.5, 1% NP40, 0.05% SDS, 0.5% Sodium Deoxycholate, 1
mM EDTA, 150 mM NaCl) followed by shaking for 20
mins at room temperature and pelleting by centrifugation
or 9 M urea, 5 mM Tris pH8 followed by boiling for 10
mins and pelleting by centrifugation. Total RNA was pre-
pared by lysing cells in 4 M GT solution as described in
[64]. The RNA was treated for 30 mins at 30°C with
TURBO DNase as outlined by the manufacturer
(Ambion), then extracted for a second time in 4 M GT
solution as before.
Secreted alkaline phosphatase (SEAP) levels were assayed
by diluting an aliquot of cell media in water and adding
10 mM diethanolamine (pH 9.5, 0.5 mM MgCl2) contain-
ing 4-nitrophenyl phosphate (1 mg/ml). SEAP levels were
measured at 405 nm using a Titertek multiscan® Plus
ELISA plate reader.
Western blots
Proteins were fractionated on sodium dodecyl sulfate-7%
(gp160/120) or 10% polyacrylamide gels (Rev, p24,
hnRNP E1, hnRNP E2, myc and tubulin) and transferred
to PVDF membrane (PALL Corporation). Blots were
probed with antibody to p24 (hybridoma line 183-H12-
5C), gp160/120 (kindly provided by H. Schaal, Heinrich-
Heine-University of Duesseldorf, Germany), hnRNP E1
(Santa Cruz Biotechnology Inc), hnRNP E2 (Santa CruzPage 14 of 18
(page number not for citation purposes)
Retrovirology 2007, 4:28 http://www.retrovirology.com/content/4/1/28Biotechnology Inc), myc (hybridoma line 9E10), Rev
(rabbit polyclonal raised against recombinant rev) and
tubulin (Sigma) and detected using HRP-conjugated anti-
mouse (p24, gp120, myc and tubulin; Jackson Immu-
noResearch Laboratories Inc), anti-rabbit (Rev; Jackson
ImmunoResearch Laboratories Inc) or anti-goat (hnRNP
E1 and hnRNP E2; Santa Cruz Biotechnology Inc) anti-
body and the Western Lightning kit (Perkin-Elmer). To
quantitate changes in Rev protein expression, developed
films were scanned and analyzed using Imagequant soft-
ware.
siRNA transfections
293 cells were washed with media minus serum/antibiot-
ics and transfected with 10 nM final concentration of
27mer siRNAs (IDT) against hnRNP E1 (E1 (3): 5'CUU
GAA UCG AGU AGG CAU CUA GAG3'; E1 (16): 5' GUA
CUG UUG GUC AUG GAG CUG UUG AUA 3'), hnRNP
E2 (5' AGA CUG UUG CAU UGC CAA CUG GUG CAG 3')
or a scrambled negative control (5' CUU CCU CUC UUU
CUC UCC CUU GGA 3'). 10 μM siRNA was combined
with OPTI-MEM (Gibco) and transfected with Oligo-
fectamine™ Reagent (Invitrogen) as per manufacturer's
instructions. The siRNA/Oligofectamine solutions were
added to cell media minus serum and antibiotics to a final
volume of 1 ml. 5 hrs later, the transfection media was
removed and replaced with growth media. The following
day, cells were transfected with HxBruR-/RI- provirus and
CMVPLAP at a ratio of 1:0.5 using Fugene (Roche) as
described in the manufacturers instructions. Two days
post transfection the cells were harvested and lysed in 9 M
urea, 5 mM Tris pH8.
Immunofluorescence
HeLa cells were plated on glass coverslips, transfected, and
processed as previously described [65]. Briefly, cells were
processed 48 hrs post transfection by washing with 1× PBS
and fixing in 4% paraformaldehyde, 1× PBS for 30 min at
room temperature. Cells were washed twice with 1× PBS,
10 mM glycine and permeabilized with 1% Triton X-100
in 1× PBS for 5 min. Cells were washed twice with 1× PBS,
10 mM glycine and blocked in 3% BSA overnight at 4°C.
Coverslips were inverted onto primary antibody and incu-
bated for 1 hr at room temperature. After washing twice in
1× PBS, 10 mM glycine, coverslips were inverted over flu-
orescently (FITC and Texas Red; Jackson ImmunoRe-
search Laboratories Inc) labeled secondary antibody and
incubated for 1 hr. Samples were washed with 1× PBS, 10
mM glycine, and stained for DAPI by washing in 1× PBS,
DAPI (50 ng/ml) for 10 min. Coverslips were mounted in
90% glycerol and analyzed using a Leica DMR epifluores-
cent microscope.
RNA analysis
RNase protection assays (RPAs) were performed as
described previously using 10 μg of total RNA [17]. Alter-
natively, nuclear and cytoplasmic fractions were prepared
as previously described [17] prior to RNA extraction.
Three RPA probes were used. The rev probe was a BamH1/
XhoI fragment of HXB-2 cloned into Bluescript. The env
and VA probes are described elsewhere (env probe: [45];
VA probe: [16]). Position of bands was determined fol-
lowing exposure to phosphor screens and scanning using
a Phosphor Imager.
For Northern blots, RNA (20 μg) was run on a 1% formal-
dehyde agarose gel in 1× gel running buffer (0.1 M MOPS
pH7, 40 mM NaAc, 5 mM EDTA pH8). The RNA was
transferred to nitrocellulose membrane (HYBOND N+,
Amersham) overnight in 5 × SSC, 10 mM NaOH and
immobilized by UV crosslinking. Membranes were prehy-
bridized at 50°C for 2 hrs in 20 ml Church buffer (0.5 M
Phosphate buffer, 7% SDS, 1 mM EDTA) and hybridized
with probe overnight at 50°C. Probe to HIV LTR was
designed to the LTR region found in all 3 classes of HIV-1
RNA and generated by PCR using the primers (F 5'CTA
ATT CAC TCC CAA CGA AGA 3'; R 5' TGC TAG AGA TTT
TCC ACA CTG 3'). GAPDH probe was generated by end
labeling the primer (5' AAA GGT GGA GGA GTG GGT
GTC GCT GTT GAA 3') with 32P γATP. Membranes were
washed in 6 × SSC for 5 mins, 6 × SSC, 0.1%SDS for 15
mins and 2 × SSC, 0.1%SDS for 15 mins all at 45°C, fol-
lowed by a brief wash in 2 × SSC at room temperature
before exposure to a phosphor screen. Membranes were
stripped by washing in boiling 0.1% SDS for 5 mins fol-
lowed by rinsing in 2 × SSC at room temperature.
For RT-PCR, cDNA was generated by incubation of 3 μg
total RNA with random hexamer and M-MLV RT as out-
lined by the manufacturer (Invitrogen). Separate RT-PCRs
were performed for the 2 kb and 4 kb classes of HIV-1
RNA. For the 2 kb class of RNA, 1 μl of cDNA was incu-
bated with 10 μM Forward primer Odp045 (5' CTG AGC
CTG GGA GCT CTC TGG C 3') and 10 μM reverse primer
Odp032 (5'CCG CAG ATC GTC CCA GAT AAG 3') and
Taq. Reactions were heated at 94°C for 2 mins, then
cycled at 94°C for 1 min, 57°C for 1 min, 68°C for 1 min
(repeated 34 times) and 68°C for 5 mins. A 1/10 dilution
of the PCR product was prepared and 3 μl used as the tem-
plate for a second PCR containing 10 μM forward and
reverse primers with Taq as before however this time 0.5
μl α32P dCTP was included. The second PCR was cycled at
94°C for 2 mins, then at 94°C for 1.5 mins, 57°C for 1
min, 68°C for 1 min (repeated 3 times) and 68°C for 5
mins.
To analyze the 4 kb class of HIV RNA, 3 μl of cDNA was
incubated with the forward primer Odp045 and reversePage 15 of 18
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3') and Taq and cycled as indicated above. For the second
PCR, 3 μl of undiluted RT-PCR reaction was used as the
template and cycled with primers Odp045 and Odp084,
as described for the 2 kb class of RNAs.
RNA affinity chromatography and mass spectrometry
pTRAP ESS and pTRAP S5-2 were linearized with XhoI and
in vitro transcribed with T7 RNA polymerase. Streptavidin
beads (62.5 μl) were pre-bound to 5–10 μg of RNA for 30
mins at 4°C. Pre-cleared HeLa nuclear extract (120 μl, 10
mg/ml) containing 0.5 M ATP, 40 mM creatine phos-
phate, 4 mM MgCl2 and 4 mM DTT was subsequently
added to the Streptavidin beads and incubated for 1 hr at
4°C. Beads were washed three times in 1× TBP (60 mM
HEPES, 10 mM NaCl and 0.1% Triton × pH 7.4). Elutions
were performed with 250 μl Biotin elution buffer (5 mM
Biotin in 1× TBP) and collected proteins precipitated with
acetone.
Column fractions were separated on SDS-PAGE gels and
detected by silver staining or Coomassie blue. Bands
enriched in the wildtype ESS3a sample were excised, and
destained in 50% 100 mM NH4HCO3/50% acetonitrile.
Gel slices were washed with 100 mM NH4HCO3, 1 mM
DTT, then 100 mM NH4HCO3, 1 mM CaCl2 and finally
dehydrated in acetonotrile. After drying to remove resid-
ual acetonitrile, gel was immersed in 100 mM NH4HCO3,
12.5 ng/μl trypsin for 45 min. on ice. An equal volume of
100 mM NH4HCO3, 1 mM CaCl2 was subsequently added
and digest continued overnight at 30°C. Following diges-
tion, peptides were separated and eluted with an organic
gradient using a reverse phase C18 microcapillary column
and analyzed in real time with a linear ion trap tandem
mass spectrometer (LTQ, ThermoFinnigan) with a cus-
tom-built ion source. Precursor peptide ions were auto-
matically selected for data-dependentfragmentation using
dynamic exclusion. The resulting tandem mass spectra
were searched against the full set of predicted ORFs down-
loaded from SGD using a distributed version of Sequest.
Confidence scores were assigned and high-confidence
protein identifications (>95% likelihood) were filtered
using the Statquest probability algorithm [66].
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